Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis

[1]  Massimo Loda,et al.  Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway* , 2003, Journal of Biological Chemistry.

[2]  K. Tsuneyama,et al.  Aberrant Expression of Trefoil Factor Family 1 in Biliary Epithelium in Hepatolithiasis and Cholangiocarcinoma , 2003, Laboratory Investigation.

[3]  M. Marchetti,et al.  Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes , 2003, Journal of Cell Science.

[4]  A. Gown,et al.  CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin: An Immunohistochemical Survey of 476 Primary and Metastatic Carcinomas , 2003, The American journal of surgical pathology.

[5]  Hiroshi Yamamoto,et al.  Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. , 2003, Biochemical and biophysical research communications.

[6]  D. Silberg,et al.  Expression of intestine‐specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas , 2003, The Journal of pathology.

[7]  Kathleen R. Cho,et al.  CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. , 2002, Gastroenterology.

[8]  K. Tsuneyama,et al.  Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. , 2002, The American journal of pathology.

[9]  P. Pandolfi,et al.  PTEN and TNF-α regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-κB-dependent pathway , 2002 .

[10]  S. Crawley,et al.  Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. , 2002, Gastroenterology.

[11]  E. Fearon,et al.  Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system , 2002, Gut.

[12]  C. Degott,et al.  Mucin gene expression in intraductal papillary‐mucinous pancreatic tumours and related lesions , 2002, The Journal of pathology.

[13]  K. Sugano,et al.  Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. , 2002, Biochemical and biophysical research communications.

[14]  Y. Jan,et al.  Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. , 2002, Human pathology.

[15]  B. Evers,et al.  Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells , 2002, Gut.

[16]  Kan Yang,et al.  Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.

[17]  K. Kaestner,et al.  Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. , 2002, Gastroenterology.

[18]  M. Koike,et al.  Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. , 2002, Cancer letters.

[19]  K. Sugano,et al.  Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia , 2002, Journal of Gastroenterology.

[20]  P. Traber,et al.  Phosphorylation of the serine 60 residue within the Cdx2 activation domain mediates its transactivation capacity. , 2001, Gastroenterology.

[21]  Y. Jan,et al.  Intraductal papillary neoplasia of the liver associated with hepatolithiasis , 2001, Hepatology.

[22]  K. Tsuneyama,et al.  Expression of MUC1 and MUC2 and carbohydrate antigen Tn change during malignant transformation of biliary papillomatosis , 2001, Histopathology.

[23]  K. Branigan,et al.  Expression and subcellular localization of cyclin D1 protein in epithelial ovarian tumour cells , 1999, British Journal of Cancer.

[24]  T. Irimura,et al.  Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma , 1999, Hepatology.

[25]  Y. Nakanuma,et al.  Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study , 1999, The Journal of pathology.

[26]  Jacqueline Capeau,et al.  Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras , 1999, Oncogene.

[27]  J. Dagorn,et al.  Expression of the Cdx1 and Cdx2 Homeotic Genes Leads to Reduced Malignancy in Colon Cancer-derived Cells* , 1998, The Journal of Biological Chemistry.

[28]  Y. Kim,et al.  Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction , 1998, Hepatology.

[29]  C. Sherr,et al.  A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin-dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase , 1997, Molecular and cellular biology.

[30]  Y. Kim,et al.  Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: An immunohistochemical study , 1996, Hepatology.

[31]  T. Terada,et al.  Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study. , 1995, The American journal of pathology.

[32]  G. Young,et al.  Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. , 1995, The American journal of pathology.

[33]  K. Imai,et al.  Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma , 1993, International journal of cancer.

[34]  T. Terada,et al.  Pathologic features of hepatolithiasis in Japan. , 1988, Human pathology.

[35]  K. Sugano,et al.  Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa , 2003, Journal of Gastroenterology.

[36]  Y. Nakanuma,et al.  Biliary papillary neoplasm of the liver. , 2002, Histology and histopathology.

[37]  Y. Jan,et al.  Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases. , 1998, Annals of surgery.